References
- Daniels G. Effect of enzymes on and chemical modifications of high-frequency red cell antigens. Immunohematology 1992;8:53–7.
- Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. Oxford, England: Blackwell Scientific Publications, 1993:318.
- Prager MD, Soules ML, Fletcher MA. Further studies on the mechanism of the effect of enzymes on erythrocyte serology with special reference to pronase. Transfusion 1968;8:220–5.
- Judson PA, Anstee DJ. Comparative effect of trypsin and chymotrypsin on blood group antigens. Med Lab Sci 1977;34:1–6.
- Parsons SF, Spring FA, Merry AH, et al. Evidence that Cromer-related blood group antigens are carried on decay accelerating factor (DAF) suggests that the Inab phenotype is a novel form of DAF deficiency (abstract). Proceedings of the XXth Congress of the International Society of Blood Transfusion, Manchester, British Blood Transfusion Society,1988:116.
- Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988;167:1993–8.
- Petty AC, Daniels GL, Anstee DJ, Tippett P. Use of the MAIEA technique to confirm the relationship between the Cromer antigens and decay-accelerating factor and to assign provisionally antigens to the short-consensus repeats. Vox Sang 1993;65:309–15.
- Lublin DM, Mallinson G, Poole J, et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994;84:1276–82.
- Telen MJ, Rao N, Udani M, Thompson ES, Kaufman RM, Lublin DM. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994;84:3205–11.
- Telen MJ, Lublin DM. Location of WESb on decay-accelerating factor (letter). Transfusion 1995;35:278.
- Spring FA, Judson PA, Daniels GL, Parsons SF, Mallinson G, Anstee DJ. A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 1987;62:307–13.
- Spring FA, Reid ME, Nicholson G. Evidence for expression of the Joa blood group antigen on the Gya/Hy-active glycoprotein. Vox Sang 1994;66:72–7.
- Banks JA, Hemming N, Poole J. Evidence that the Gya, Hy and Joa antigens belong to the Dombrock blood group system. Vox Sang 1995;68:177–82.
- Spring FA, Herron R, Rowe G. An erythrocyte glycoprotein of apparent Mr 60,000 expresses the Sc1 and Sc2 antigens. Vox Sang 1990;58:122–5.
- Spring FA. Characterization of blood-group-active erythrocyte membrane glycoproteins with human antisera. Transfus Med 1993;3:167–78.
- Mallinson G, Soo KS, Schall TJ, Pisacka M, Anstee DJ. Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995;90:823–9.
- Bruce LJ, Anstee DJ, Spring FA, Tanner MJ. Band 3 Memphis variant II. Altered stilbene disulfonate binding and the Diego (Dia) blood group antigen are associated with the human erythrocyte band 3 mutation Pro854→Leu. J Biol Chem 1994;269:16155–8.
- Bruce LJ, Ring SM, Anstee DJ, Reid ME, Wilkinson S, Tanner MJA. Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: a site of interaction between band 3 and glycophorin A under certain conditions. Blood 1995;85:541–7.
- Smythe JS, Spring FA, Gardner B, Parsons SF, Judson PA, Anstee DJ. Monoclonal antibodies recognizing epitopes on the extracellular face and intracellular N-terminus of the human erythrocyte anion transporter (band 3) and their application to the analysis of South East Asian ovalocytes. Blood 1995;85:2929–36.
- Lomas CG, Tippett P. Use of enzymes in distinguishing anti-LWa and anti-LWab from anti-D. Med Lab Sci 1985;42:88–9.